Immunotherapy – teaching the immune system to fight cancer – receives new FDA approval

The concept of ‘teaching’ the immune system to recognize and destroy cancer cells is over a century old, but the development of immunotherapeutic strategies for cancer was slow for many decades. However, much has been learned about the immune system in the meantime, and with the recent approval of two new immunotherapeutic anticancer drugs and several drugs in late-stage development, a new era in anticancer immunotherapy is beginning.

The video takes an audio-visual journey through the different approaches that are being investigated to harness the immune system to treat cancer.

 

For more, check out the Nature Reviews Drug Discovery poster (pdf):

 

 

// Thx to Derya Unutmaz

Leave a Reply

Your email address will not be published. Required fields are marked *